Trial Outcomes & Findings for Hospital to Home Outcomes (NCT NCT02081846)

NCT ID: NCT02081846

Last Updated: 2019-04-16

Results Overview

The dependent variable will be a dichotomized indicator of any occurrence of unplanned rehospitalization and/or any emergency department/urgent care visit within 30-days post-discharge (i.e. unplanned reutilization). Differences in this outcome between intervention and control groups will be evaluated using logistic regression with the stratification variables (neighborhood poverty and complex versus noncomplex teams) included in the model.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1500 participants

Primary outcome timeframe

30 days post-discharge

Results posted on

2019-04-16

Participant Flow

Patients hospitalized on the hospital medicine or neurosciences services (neurology/ neurosurgery) at Cincinnati Children's Hospital Medical Center (CCHMC), a freestanding tertiary care children's hospital, between 2/2015 and 4/2016 were eligible for study recruitment.

Participant milestones

Participant milestones
Measure
Home Nurse Visit
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Overall Study
STARTED
751
749
Overall Study
COMPLETED
749
749
Overall Study
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Home Nurse Visit
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Overall Study
Withdrawal by Subject
1
0
Overall Study
invalid consent
1
0

Baseline Characteristics

Hospital to Home Outcomes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=749 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Total
n=1498 Participants
Total of all reporting groups
Age, Continuous
2.1 years
n=5 Participants
1.9 years
n=7 Participants
2.0 years
n=5 Participants
Sex: Female, Male
Female
357 Participants
n=5 Participants
364 Participants
n=7 Participants
721 Participants
n=5 Participants
Sex: Female, Male
Male
392 Participants
n=5 Participants
385 Participants
n=7 Participants
777 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
34 Participants
n=5 Participants
31 Participants
n=7 Participants
65 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
704 Participants
n=5 Participants
709 Participants
n=7 Participants
1413 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
11 Participants
n=5 Participants
9 Participants
n=7 Participants
20 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · White
453 Participants
n=5 Participants
456 Participants
n=7 Participants
909 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Black or African American
219 Participants
n=5 Participants
210 Participants
n=7 Participants
429 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · American Indian or Alaska Native
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Asian/Oriental or Pacific Islander
3 Participants
n=5 Participants
10 Participants
n=7 Participants
13 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Other
64 Participants
n=5 Participants
62 Participants
n=7 Participants
126 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Unknown/missing
9 Participants
n=5 Participants
8 Participants
n=7 Participants
17 Participants
n=5 Participants
Region of Enrollment
United States
749 Participants
n=5 Participants
749 Participants
n=7 Participants
1498 Participants
n=5 Participants
Length of Stay
2 days
n=5 Participants
2 days
n=7 Participants
2 days
n=5 Participants

PRIMARY outcome

Timeframe: 30 days post-discharge

Population: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).

The dependent variable will be a dichotomized indicator of any occurrence of unplanned rehospitalization and/or any emergency department/urgent care visit within 30-days post-discharge (i.e. unplanned reutilization). Differences in this outcome between intervention and control groups will be evaluated using logistic regression with the stratification variables (neighborhood poverty and complex versus noncomplex teams) included in the model.

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=749 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge
133 Participants
105 Participants

SECONDARY outcome

Timeframe: 14 days post-discharge

Population: The analysis population includes the total subjects completing the 14-day phone call survey. Of the total randomized (1,500: 751 intervention, 749 control), 29 were excluded from the intervention group and 26 from the control group.

Post-Discharge Difficulty Coping Scale (Weiss, et. al) measured at 14 day post-discharge phone call. Post-Discharge Coping Difficulty Scale uses an 11 point scaling format (0-10) with total scores ranging from 0 to 100. Higher scores represent greater coping difficulty.

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=722 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=723 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Post Discharge Coping Difficulty Scale
20.4 units on a scale
Interval 19.1 to 21.8
21.2 units on a scale
Interval 19.8 to 22.5

SECONDARY outcome

Timeframe: 14 days post-discharge

Population: The analysis population includes the total subjects completing the 14-day phone call survey with a response for the return to normalcy question. Of the total randomized (1,500: 751 intervention, 749 control), 30 were excluded from the intervention group and 26 from the control group with no data available for this outcome.

Number of days until normalcy: measured at post discharge phone call. Parents asked to recall the number of days it took to "return to a 'normal' routine" including the return to work and school (with option of not yet be back to normal).

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=721 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=723 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Days Until Normalcy
4.16 days
Interval 3.87 to 4.44
4.11 days
Interval 3.82 to 4.4

SECONDARY outcome

Timeframe: 14 days post-discharge

Population: The analysis population includes the total subjects completing the 14-day phone call survey. Of the total randomized (1,500: 751 intervention, 749 control), 29 were excluded from the intervention group and 26 from the control group for not completing the 14-day phone call survey.

This was measured at the 14 day post-discharge phone call survey. Parents were asked to recall "any red flags or warning signs" to indicate the "child's condition was getting worse." The number of red flags recalled could range from 0-10 depending on the template used. The template was a home visit guideline for nurses to use that was specific to the child's illness. For example, if the child had bronchiolitis the nurse would use the template "bronchiolitis/croup/pneumonia" to guide them through the visit. Higher values (i.e., the greater number of red flags remembered) represent a better outcome.

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=722 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=723 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Red Flags Remembered
1.91 units on a scale
Interval 1.78 to 2.04
1.61 units on a scale
Interval 1.5 to 1.73

SECONDARY outcome

Timeframe: 30 days

Population: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).

Occurrence(s) of an unplanned readmission within 30 days post-discharge.

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=749 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Number of Participants With Occurrence(s) of an Unplanned Readmission Within 30 Days Post-discharge
58 Participants
41 Participants

SECONDARY outcome

Timeframe: 30 days

Population: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).

Occurrence(s) of an ED visit within 30 days post-discharge

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=749 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Number of Participants With Occurrence(s) of an Emergency Department Visit Within 30 Days Post-discharge
75 Participants
54 Participants

SECONDARY outcome

Timeframe: 14 days post-discharge

Population: The analysis population includes the total 1,500 (751 intervention, 749 control) randomized excluding the two subjects withdrawn in the intervention group after randomization (1 due to invalid consent, 1 requested withdrawal).

Occurrence(s) of 14-day unplanned healthcare utilization defined by unplanned re-hospitalization and/or any emergency/urgent care visit within 14 days or parent report of an unplanned visit to one of these places. Parent report is collected at the 14 day follow-up phone call.

Outcome measures

Outcome measures
Measure
Home Nurse Visit
n=749 Participants
Families in this arm will receive a nurse home visit within 96 hours of discharge. Nurse Home Visit: We will complete a single center, parallel, randomized, standard-of-care-controlled prospective study to determine the efficacy of a nurse home visit program, an intervention adapted from those studied in other populations (i.e., adults, high-risk infants) and re-engineered through Aim 2, in improving pediatric patient transitions from hospital to home
Control
n=749 Participants
This arm will receive standard of care. Standard of Care: Control patients will be randomized to receive standard-of-care at discharge. This care at our institution includes pediatric hospitalist to PCP (primary care physician) verbal and written communication prior to discharge, written documentation for the family regarding prescribed medication regimen, recommended follow-up with outpatient PCP and relevant consultant(s), and delivery of prescribed medications from the hospital pharmacy to the patient's bedside.
Number of Participants With Occurrence(s) of 14-day Unplanned Healthcare Utilization
132 Participants
110 Participants

Adverse Events

Home Nurse Visit

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Heidi Sucharew (Biostatistician)

Cincinnati Children's Hospital Medical Center

Phone: 513-803-1920

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place